These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
3. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
5. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
6. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential. Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290 [TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance. Gatenby P; Bhattacharjee S; Wall C; Caygill C; Watson A World J Gastroenterol; 2016 Dec; 22(48):10592-10600. PubMed ID: 28082811 [TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Cameron AJ; Carpenter HA Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304 [TBL] [Abstract][Full Text] [Related]
11. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470 [TBL] [Abstract][Full Text] [Related]
12. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814 [TBL] [Abstract][Full Text] [Related]
13. Surveillance in Barrett's esophagus: an audit of practice. Ajumobi A; Bahjri K; Jackson C; Griffin R Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878 [TBL] [Abstract][Full Text] [Related]
14. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia. Donnellan F; Harewood GC; Patchett SE Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322 [No Abstract] [Full Text] [Related]
15. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance]. Burdiles P; Csendes A; Smok G; Braghetto I; Korn O Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585 [TBL] [Abstract][Full Text] [Related]
16. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
17. Surgical management of high-grade dysplasia in Barrett's esophagus. Rice TW; Falk GW; Achkar E; Petras RE Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928 [TBL] [Abstract][Full Text] [Related]
18. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW; Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191 [TBL] [Abstract][Full Text] [Related]
19. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis. Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044 [TBL] [Abstract][Full Text] [Related]
20. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus. Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]